stockrowCorcept Therapeutics Incorporated
CORT Healthcare Biotechnology
Corcept Therapeutics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $761.4 million, up 12.8% from fiscal 2024.
- Revenue
- +64.0%
- EPS
- +525.8%
- Free cash flow
- +161.0%
Quarter to September 2026, against a year earlier
Follow CORT
Alert me
Corcept Therapeutics Incorporated (CORT) Operating cash flow
Corcept Therapeutics Incorporated's operating cash flow for fiscal 2025 was $142.0M, down 28.4% from $198.3M in fiscal 2024. Over the twelve months to 30 September 2026 it was $198.1M. Over the past ten years it has ranged from $3.1M (fiscal 2015) to $198.3M (fiscal 2024); the current reading is higher than 73% of that period. Corcept Therapeutics Incorporated ranks 21st of 603 Biotechnology companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $142.0M | (28.39%) |
| FY2024 | $198.3M | 56.53% |
| FY2023 | $126.7M | 5.28% |
| FY2022 | $120.3M | (28.33%) |
| FY2021 | $167.9M | 10.48% |
| FY2020 | $152.0M | 11.65% |
| FY2019 | $136.1M | 17.68% |
| FY2018 | $115.7M | 89.82% |
| FY2017 | $60.9M | 231.33% |
| FY2016 | $18.4M | 487.57% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $142.9M | 325.99% |
| Jun 2026 | $33.5M | — |
| Mar 2026 | −$16.8M | — |
| Dec 2025 | $38.4M | (29.43%) |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| KRYS Krystal Biotech, Inc. compare | $323.9M |
| CORT Corcept Therapeutics Incorporated | $198.1M |
| PTGX Protagonist Therapeutics, Inc. compare | $131.2M |
| ARWR Arrowhead Pharmaceuticals, Inc. compare | −$59.1M |
| MDGL Madrigal Pharmaceuticals, Inc. compare | −$157.0M |
| ABVX Abivax SA Sponsored ADR compare | −$225.9M |
| SYRE Spyre Therapeutics, Inc. compare | −$249.3M |
| PRAX Praxis Precision Medicines, Inc. compare | −$305.1M |
| CYTK Cytokinetics, Incorporated compare | −$572.0M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on CORT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement